To investigate the perioperative and morbidity outcomes after partial nephrectomy (PN) in patients with short life expectancy (SLE) (≥95% 10-year expected mortality (10y-EM)), to assess the main predictors of outcomes in this population and to compare these results with those of a group at the opposite upper range with long LE (LLE, ≤5% 10y-EM) relying on a multicenter Italian prospective registry of kidney surgery (the RECORD 2 project).

Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study / Gontero, Paolo; Mari, Andrea; Marra, Giancarlo; Nazzani, Sebastiano; Allasia, Marco; Antonelli, Alessandro; Barale, Maurizio; Brunocilla, Eugenio; Capitanio, Umberto; Di Maida, Fabrizio; Gallioli, Andrea; Longo, Nicola; Montorsi, Francesco; Porpiglia, Francesco; Porreca, Angelo; Rocco, Bernardo; Simeone, Claudio; Schiavina, Riccardo; Tellini, Riccardo; Terrone, Carlo; Villari, Donata; Ficarra, Vincenzo; Carini, Marco; Minervini, Andrea. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 39:1(2021), pp. 78.e17-78.e26. [10.1016/j.urolonc.2020.09.022]

Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study

Longo, Nicola;
2021

Abstract

To investigate the perioperative and morbidity outcomes after partial nephrectomy (PN) in patients with short life expectancy (SLE) (≥95% 10-year expected mortality (10y-EM)), to assess the main predictors of outcomes in this population and to compare these results with those of a group at the opposite upper range with long LE (LLE, ≤5% 10y-EM) relying on a multicenter Italian prospective registry of kidney surgery (the RECORD 2 project).
2021
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study / Gontero, Paolo; Mari, Andrea; Marra, Giancarlo; Nazzani, Sebastiano; Allasia, Marco; Antonelli, Alessandro; Barale, Maurizio; Brunocilla, Eugenio; Capitanio, Umberto; Di Maida, Fabrizio; Gallioli, Andrea; Longo, Nicola; Montorsi, Francesco; Porpiglia, Francesco; Porreca, Angelo; Rocco, Bernardo; Simeone, Claudio; Schiavina, Riccardo; Tellini, Riccardo; Terrone, Carlo; Villari, Donata; Ficarra, Vincenzo; Carini, Marco; Minervini, Andrea. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 39:1(2021), pp. 78.e17-78.e26. [10.1016/j.urolonc.2020.09.022]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/820846
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact